Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme

Abstract excerpt

BACKGROUND: Glioblastoma multiforme (GBM) is the most malignant type of glioma. GBM tumors grow rapidly, have a high degree of malignancy, and are characterized by a fast disease progression. Unfortunately, there is a lack of effective treatments. An effective strategy for the treatment of GBM would be to identify key biomarkers correlating with the occurrence and progression of GBM and developing these...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Mechanisms and Therapy
• Share to Ferroptosis and cancer prognosis
• Share to Glioma Diagnosis and Treatment